These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 21270825)

  • 21. Aicardi-Goutières syndrome.
    Crow YJ
    Handb Clin Neurol; 2013; 113():1629-35. PubMed ID: 23622384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups.
    Namjou B; Sestak AL; Armstrong DL; Zidovetzki R; Kelly JA; Jacob N; Ciobanu V; Kaufman KM; Ojwang JO; Ziegler J; Quismorio FP; Reiff A; Myones BL; Guthridge JM; Nath SK; Bruner GR; Mehrian-Shai R; Silverman E; Klein-Gitelman M; McCurdy D; Wagner-Weiner L; Nocton JJ; Putterman C; Bae SC; Kim YJ; Petri M; Reveille JD; Vyse TJ; Gilkeson GS; Kamen DL; Alarcón-Riquelme ME; Gaffney PM; Moser KL; Merrill JT; Scofield RH; James JA; Langefeld CD; Harley JB; Jacob CO
    Arthritis Rheum; 2009 Apr; 60(4):1085-95. PubMed ID: 19333953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by Whole-exome sequencing.
    Ellyard JI; Jerjen R; Martin JL; Lee AY; Field MA; Jiang SH; Cappello J; Naumann SK; Andrews TD; Scott HS; Casarotto MG; Goodnow CC; Chaitow J; Pascual V; Hertzog P; Alexander SI; Cook MC; Vinuesa CG
    Arthritis Rheumatol; 2014 Dec; 66(12):3382-6. PubMed ID: 25138095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Goutières syndrome.
    Haaxma CA; Crow YJ; van Steensel MA; Lammens MM; Rice GI; Verbeek MM; Willemsen MA
    Am J Med Genet A; 2010 Oct; 152A(10):2612-7. PubMed ID: 20799324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aicardi-Goutières syndrome protein TREX1 suppresses L1 and maintains genome integrity through exonuclease-independent ORF1p depletion.
    Li P; Du J; Goodier JL; Hou J; Kang J; Kazazian HH; Zhao K; Yu XF
    Nucleic Acids Res; 2017 May; 45(8):4619-4631. PubMed ID: 28334850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and molecular phenotype of Aicardi-Goutieres syndrome.
    Rice G; Patrick T; Parmar R; Taylor CF; Aeby A; Aicardi J; Artuch R; Montalto SA; Bacino CA; Barroso B; Baxter P; Benko WS; Bergmann C; Bertini E; Biancheri R; Blair EM; Blau N; Bonthron DT; Briggs T; Brueton LA; Brunner HG; Burke CJ; Carr IM; Carvalho DR; Chandler KE; Christen HJ; Corry PC; Cowan FM; Cox H; D'Arrigo S; Dean J; De Laet C; De Praeter C; Dery C; Ferrie CD; Flintoff K; Frints SG; Garcia-Cazorla A; Gener B; Goizet C; Goutieres F; Green AJ; Guet A; Hamel BC; Hayward BE; Heiberg A; Hennekam RC; Husson M; Jackson AP; Jayatunga R; Jiang YH; Kant SG; Kao A; King MD; Kingston HM; Klepper J; van der Knaap MS; Kornberg AJ; Kotzot D; Kratzer W; Lacombe D; Lagae L; Landrieu PG; Lanzi G; Leitch A; Lim MJ; Livingston JH; Lourenco CM; Lyall EG; Lynch SA; Lyons MJ; Marom D; McClure JP; McWilliam R; Melancon SB; Mewasingh LD; Moutard ML; Nischal KK; Ostergaard JR; Prendiville J; Rasmussen M; Rogers RC; Roland D; Rosser EM; Rostasy K; Roubertie A; Sanchis A; Schiffmann R; Scholl-Burgi S; Seal S; Shalev SA; Corcoles CS; Sinha GP; Soler D; Spiegel R; Stephenson JB; Tacke U; Tan TY; Till M; Tolmie JL; Tomlin P; Vagnarelli F; Valente EM; Van Coster RN; Van der Aa N; Vanderver A; Vles JS; Voit T; Wassmer E; Weschke B; Whiteford ML; Willemsen MA; Zankl A; Zuberi SM; Orcesi S; Fazzi E; Lebon P; Crow YJ
    Am J Hum Genet; 2007 Oct; 81(4):713-25. PubMed ID: 17846997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity.
    Crow YJ; Rehwinkel J
    Hum Mol Genet; 2009 Oct; 18(R2):R130-6. PubMed ID: 19808788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Cyclic GMP-AMP Synthase Using a Novel Antimalarial Drug Derivative in Trex1-Deficient Mice.
    An J; Woodward JJ; Lai W; Minie M; Sun X; Tanaka L; Snyder JM; Sasaki T; Elkon KB
    Arthritis Rheumatol; 2018 Nov; 70(11):1807-1819. PubMed ID: 29781188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of DNase IV polymorphisms with autoantibodies in patients with systemic lupus erythematosus.
    Kim I; Hur NW; Shin HD; Park BL; Cheong HS; Bae SC
    Rheumatology (Oxford); 2008 Jul; 47(7):996-9. PubMed ID: 18417526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease.
    Grieves JL; Fye JM; Harvey S; Grayson JM; Hollis T; Perrino FW
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5117-22. PubMed ID: 25848017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis.
    Kisla Ekinci RM; Balci S; Bisgin A; Altintas DU; Yilmaz M
    Eur J Med Genet; 2017 Dec; 60(12):690-694. PubMed ID: 28919362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib.
    Zhang S; Song J; Yang Y; Miao H; Yang L; Liu Y; Zhang X; Liu Y; Wang T
    Pediatr Rheumatol Online J; 2021 Jan; 19(1):1. PubMed ID: 33407657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring TREX1 and TREX2 exonuclease activities.
    Hemphill WO; Perrino FW
    Methods Enzymol; 2019; 625():109-133. PubMed ID: 31455522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-17A haplotype confers susceptibility to systemic lupus erythematosus but not to rheumatoid arthritis in Mexican patients.
    Montúfar-Robles I; Barbosa-Cobos RE; Alemán-Ávila I; Ramírez-Bello J
    Int J Rheum Dis; 2019 Mar; 22(3):473-479. PubMed ID: 30398030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Alleles Associated with SLE Susceptibility and Clinical Manifestations in Hispanic Patients from the Dominican Republic.
    Liu Z; Yu Y; Yue Y; Hearth-Holmes M; Lopez PD; Tineo C; Paulino G; Fu WN; Loyo E; Su K
    Curr Mol Med; 2019; 19(3):164-171. PubMed ID: 31032751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic variability of a TREX1 variant in Aicardi-Goutieres type 1 patients from the Indian subcontinent.
    Abraham SSC; Yoganathan S; Koshy B; Oommen SP; Simon A; Mathai S; Korula S; Mathew L; Sathishkumar D; Jasper A; George R; Danda S
    Eur J Med Genet; 2021 Sep; 64(9):104291. PubMed ID: 34303877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
    Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
    Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome.
    Fye JM; Orebaugh CD; Coffin SR; Hollis T; Perrino FW
    J Biol Chem; 2011 Sep; 286(37):32373-82. PubMed ID: 21808053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between vitamin D receptor polymorphisms and systemic lupus erythematosus in an Indian cohort.
    Mahto H; Tripathy R; Das BK; Panda AK
    Int J Rheum Dis; 2018 Feb; 21(2):468-476. PubMed ID: 29230954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycoprotein 96 polymorphisms are associated with the risk of systemic lupus erythematosus: A case-control study.
    Lee JS; Im CH; Lee SJ; Choi JY; Han JM; Kim S; Kim DJ; Park T; Lee EY; Song YW
    Int J Rheum Dis; 2019 May; 22(5):905-912. PubMed ID: 30860673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.